Published on 01/12/2025

Governance Minutes for Change Boards

Introduction to Serialization and Aggregation Change Control

The pharmaceutical industry continues to face increasing regulatory scrutiny and market pressures, necessitating robust frameworks for managing serialization and aggregation processes. Serialization involves assigning unique identifiers to products, while aggregation refers to the linking of these identifiers in a hierarchical manner. Effective governance in these areas is crucial for ensuring compliance with regulations such as the Drug Supply Chain Security Act (DSCSA) in the US and the EU FMD (Falsified Medicines Directive) requirements.

This article provides a comprehensive step-by-step guide for governance minutes for change boards in the context of serialization change control. It is essential for professionals involved in quality assurance, regulatory affairs, and clinical operations to understand the intricacies of change management within the framework of controlled testing, master data flows, and audit trail reviews.

Step 1: Establishing a Governance Framework

Before initiating any serialization and aggregation project, establishing a governance framework is paramount. This framework should define the roles, responsibilities, and processes involved in overseeing the project. Key elements include:

• Project Leadership: Appoint a project lead with the requisite expertise in serialization, aggregation, and compliance regulations.
• Cross-Functional Teams: Assemble teams that include members from IT, Quality Assurance, Regulatory Affairs, and Supply Chain to ensure a holistic approach.
• Regular Meetings: Schedule regular governance meetings to discuss progress, challenges, and changes.
• Risk Management: Document potential risks and their mitigations, ensuring that these risks are reviewed regularly.

Incorporating all stakeholders early in the process can enhance buy-in and provide diverse insights into challenges that may arise during implementation.

Step 2: Defining User Requirements Specifications (URS)

User Requirements Specifications (URS) are critical documents that outline the expectations for the serialization and aggregation system. A well-defined URS ensures clarity in functionality, compliance needs, and testing requirements. Key components of a URS include:

• Functionality Requirements: Describe the necessary features for serialization and aggregation, including data entry, data retrieval, and reporting capabilities.
• Compliance Requirements: List regulatory requirements including EU FMD requirements and international standards.
• Data Integrity Requirements: Address the ALCOA+ principles (Attributable, Legible, Contemporaneous, Original, and Accurate) to ensure data integrity throughout the system.

The URS will serve as the foundation for all subsequent testing and validation activities. It should be reviewed and approved by relevant stakeholders to align expectations and requirements for the serialization system.

Step 3: Design and Configuration of the Serialization and Aggregation System

Once the URS is established, the next step involves the design and configuration of the serialization and aggregation system in compliance with defined specifications. This step typically encompasses:

• System Architecture: Outline system components, including hardware, software, and network configurations essential for achieving interoperability and data sharing.
• Master Data Management: Establish master data flows that dictate how product information will be processed, ensuring data is accurate and consistent across systems.
• Integration Requirements: Determine how different systems (e.g., ERP, WMS) will communicate and share data, especially relevant for aggregation hierarchies.

In this stage, collaboration between IT, operational, and quality assurance teams is crucial to ensure all specifications are effectively implemented in the configured system.

Step 4: Testing the Serialization and Aggregation Process

The testing phase is vital to ensure the serialized products and aggregation processes work as intended. A structured testing methodology should include:

• Controlled Testing Environment: Set up a controlled environment that mirrors production settings to conduct testing without affecting operational workflows.
• Test Planning: Develop detailed test plans that define the scope, approach, resources, and activities involved in testing the software and system.
• Execution of Tests: Execute various test scenarios, including unit testing, integration testing, system testing, and user acceptance testing (UAT). Each test should verify specific requirements outlined in the URS.

The results of these tests must be documented accurately, as they will serve as evidence of compliance during audits and regulatory inspections.

Step 5: Exception Handling and Rework Protocols

No system is perfect, and it is essential to prepare for exceptions that may arise during serialization and aggregation processes. Establishing clear exception handling protocols ensures that issues are documented and addressed promptly. This can involve:

• Exception Handling Procedures: Develop specific procedures for identifying, reporting, and resolving exceptions. This includes when products cannot be serialized correctly or when data mismatches occur.
• Rework Guidelines: Outline the steps to take when reworking items that had an initial serialization error to ensure they meet compliance standards post-correction.
• Training Staff: Regularly train staff involved in handling exceptions and understanding the reconciliation rules to maintain compliance with ALCOA+ standards.

Your organization must implement a culture of continuous improvement, promoting proactive measures to minimize recurrence of errors and exceptions in the serialization process.

Step 6: Audit Trail Review and Change Control Management

An essential aspect of serialization governance involves maintaining comprehensive audit trails and managing changes in the serialization and aggregation process. Key practices include:

• Audit Trails: Ensure system-generated audit trails capture all activities and changes related to serialization, providing clear visibility into the system’s historical data.
• Change Control Documentation: Any changes to the serialization process must follow a defined change control process, including impact assessments and approvals from the change board.
• CAPA Procedures: Establish Corrective and Preventive Action (CAPA) procedures to address audit findings and continuously enhance the process based on identified issues.

Regular audits should also be scheduled to verify compliance and readiness for any regulatory inspections by authorities like the International Conference on Harmonisation (ICH), as well as local competent authorities.

Step 7: Continuous Monitoring and Compliance Maintenance

The achievement of compliance is an ongoing effort; thus, organizations should continuously monitor their serialization and aggregation practices to ensure they align with the latest regulatory updates. This should include:

• Regular Training Sessions: Conduct training for staff to ensure all teams are aware of the current regulations and company policies regarding serialization and aggregation.
• Regulatory Updates Tracking: Stay informed on the evolving landscape of regulations related to serialization and data integrity, ensuring that the company promptly adapts to changes.
• Performance Metrics: Define performance metrics for evaluating the effectiveness of the serialization system, including error rates, reconciliation efficiency, and exception handling success.

Continuous improvement practices can lead to a more resilient and effective serialization process that adapts to changing requirements and maintains compliance with DSCSA and EU FMD mandates.

Conclusion

Implementing effective governance minutes for change boards within serialization and aggregation frameworks is essential for fostering compliance with both local and international requirements. By following the steps outlined in this article, pharmaceutical companies can enhance the integrity of their systems, maintain compliance with global standards, and effectively manage change control processes.

Establishing a robust change management process enhances the quality and security of pharmaceutical products, ultimately leading to improved patient safety and trust in the pharmaceutical supply chain.